Examkin

Soru

Zorluk: ZorPulmonary and Critical Care

A 62-year-old man presents to the clinic for a routine health maintenance examination and preoperative clearance for an upcoming elective inguinal hernia repair. He feels well and reports no cough, dyspnea, hemoptysis, weight loss, or chest pain. He has a 45-pack-year smoking history but quit 2 years ago. A routine preoperative chest radiograph reveals a newly identified 14 mm14\text{ mm} distinct, rounded opacity in the peripheral right upper lobe.

Assuming the clinical findings at each stage continue to indicate an intermediate-to-high clinical probability of malignancy, arrange the following diagnostic interventions in the most appropriate chronological sequence for evaluating this patient's pulmonary nodule.

  1. 1Request and review the patient's previous chest radiographs
  2. 2Obtain a noncontrast thin-section computed tomography (CT) scan of the chest
  3. 3Perform a whole-body 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) scan
  4. 4Perform a percutaneous CT-guided core needle biopsy of the lesion

Cevap

The correct chronological sequence for evaluating a newly discovered solitary pulmonary nodule >8 mm is: (1) Review prior imaging, (2) Perform a chest CT, (3) Obtain a PET scan, and (4) Perform a tissue biopsy.
The evaluation of a solitary pulmonary nodule (SPN) follows a strict risk-stratification algorithm to minimize invasive procedures for benign lesions. The very first step for any newly identified SPN is to review prior chest imaging to establish temporal stability. If prior imaging is unavailable or shows growth, a noncontrast chest CT is required to characterize the nodule's anatomy and estimate the risk of malignancy. For nodules >8 mm>8\text{ mm} with an intermediate-to-high risk (as expected in a 62-year-old heavy smoker), an FDG-PET scan is the next indicated step to assess for metabolic activity and rule out occult nodal metastasis. If the PET scan is avid (positive), the patient proceeds to a definitive tissue diagnosis, typically via a CT-guided percutaneous biopsy for peripheral lesions or bronchoscopy for central lesions.

Adım Adım Çözüm

1
Review prior chest radiographs.
Determines the temporal stability of the nodule.
A nodule stable for >24 months>24\text{ months} is generally considered benign, safely stopping the diagnostic algorithm early and preventing unnecessary invasive procedures.
2
Obtain a noncontrast CT scan of the chest.
Provides high-resolution anatomical characterization.
CT accurately measures the true dimensions (e.g., 14 mm14\text{ mm}) and evaluates morphological features (margins, calcification) to estimate the pre-test clinical probability of malignancy.
3
Perform an FDG-PET scan.
Evaluates the metabolic activity of the nodule and regional lymph nodes.
For intermediate-to-high risk nodules >8 mm>8\text{ mm}, PET helps determine the likelihood of malignancy and identifies the safest, highest-yield potential sites for biopsy.
4
Perform a CT-guided core needle biopsy.
Obtains targeted lung tissue for definitive histopathologic diagnosis.
Required for a definitive histologic diagnosis when the non-invasive workup (CT, PET) suggests a high suspicion for malignancy, guiding final surgical or oncologic management.

Anahtar Kavram

Chronological algorithm for the evaluation of a solitary pulmonary nodule (SPN)
Bu soruyu puanla

Konular

Pulmonary and Critical Care

Bu konudan daha fazla soru